reiterateMYGNfinnhub
Stephens & Co. Reiterates Equal-Weight Rating on Myriad Genetics, Inc. (MYGN)
Stephens & Co. reiterated its Equal-Weight rating on Myriad Genetics, Inc.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Stephens & Co. reiterated its Equal-Weight rating on Myriad Genetics, Inc.
Read moreHC Wainwright & Co. reiterated its Buy rating on Amylyx Pharmaceuticals, Inc.
Read moreCitizens reiterated its Market Outperform rating on Walker & Dunlop, Inc. (NYSE:WD) on August 18, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Intuitive Machines, Inc. (NASDAQ:LUNR) on August 18, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Kinetik Holdings Inc. (NASDAQ:KNTK) on August 18, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Travel + Leisure Co. (NYSE:TNL) on August 18, 2026.
Read moreKeybanc analysts downgraded Kite Realty Group Trust (NYSE:KRG) from Overweight to Sector Weight on August 18, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Plains All American Pipeline, L.P. (NASDAQ:PAA) on August 18, 2026.
Read moreRBC Capital reiterated its Outperform rating on Huntington Bancshares Incorporated (NASDAQ:HBANL) on August 18, 2026.
Read moreBarclays reiterated its Overweight rating on Veeva Systems Inc. (NYSE:VEEV) on August 18, 2026.
Read moreUBS reiterated its Neutral rating on Corteva, Inc. (NYSE:CTVA) on August 18, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Digital Realty Trust, Inc. (NYSE:DLR) on August 18, 2026.
Read moreBTIG reiterated its Buy rating on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) on August 18, 2026.
Read moreChardan Capital analysts initiated coverage on Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) with a rating of Buy on August 18, 2026.
Read moreTD Cowen reiterated its Hold rating on J.Jill, Inc. (NYSE:JILL) on August 18, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Pyxis Oncology, Inc.
Read moreJP Morgan reiterated its Overweight rating on Evolent Health, Inc. (NYSE:EVH) on August 18, 2026.
Read moreMizuho reiterated its Outperform rating on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) on August 18, 2026.
Read moreBTIG reiterated its Buy rating on CeriBell, Inc. Common Stock (NASDAQ:CBLL) on August 18, 2026.
Read moreBaird analysts downgraded Ramaco Resources, Inc. - 9.00% (NASDAQ:METCL) from Outperform to Neutral on August 18, 2026.
Read more